Methylcrotonoyl-Coa Carboxylase 2 Overexpression Predicts An Unfavorable Prognosis and Promotes Cell Proliferation in Breast Cancer

References

• Torre LA , BrayF, SiegelRL, FerlayJ, Lortet-TieulentJ, JemalA. Global cancer statistics, 2012. CA Cancer J. Clin.65, 87–108 (2015).
   PubMed Web of Science ®Google Scholar
• Oltmann J , Heselmeyer-HaddadK, HernandezLSet al. Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients. Genes Chromosomes Cancer57 (4), 165–175 (2018).
   PubMed Web of Science ®Google Scholar
• Chen S , CaiJ, ZhangWet al. Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int. J. Oncol.45 (1), 448–458 (2014).
   PubMed Web of Science ®Google Scholar
• Tryfonidis K , BasaranG, BogaertsJet al. A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre Phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378). Eur. J. Cancer53, 144–154 (2016).
   PubMed Web of Science ®Google Scholar
• Guo W , ZhangM, ChenY, GuoS. The clinical significance of secreted protein acidic and rich in cysteine expression in breast cancer tissue and its association with prognosis. J. Cancer Res. Ther.13 (5), 833–836 (2017).
   PubMed Web of Science ®Google Scholar
• Gao SP , SunHF, FuWYet al. High expression of COX5B is associated with poor prognosis in breast cancer. Future Oncol.13 (19), 1711–1719 (2017).
   PubMed Web of Science ®Google Scholar
• Arsene-Henry A , FourquetA, KirovaYM. Evolution of radiation techniques in the treatment of breast cancer (BC) patients: from 3D conformal radiotherapy (3D CRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT). Radiother. Oncol.124 (2), 333–334 (2017).
   PubMed Web of Science ®Google Scholar
• Li G , HuJ, HuG. Biomarker studies in early detection and prognosis of breast cancer. Adv. Exp. Med. Biol.1026, 27–39 (2017).
   PubMed Web of Science ®Google Scholar
• Kazarian A , BlyussO, MetodievaGet al. Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples. Br. J. Cancer116 (4), 501–508 (2017).
   PubMed Web of Science ®Google Scholar
• Morscher RJ , GrunertSC, BurerCet al. A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency. Mol. Genet. Metab.105 (4), 602–606 (2012).
   PubMed Web of Science ®Google Scholar
• Yang L , YangJ, ZhangTet al. Identification of eight novel mutations and transcript analysis of two splicing mutations in Chinese newborns with MCC deficiency. Clin. Genet.88 (5), 484–488 (2015).
   PubMed Web of Science ®Google Scholar
• Rips J , AlmashanuS, MandelHet al. Primary and maternal 3-methylcrotonyl-CoA carboxylase deficiency: insights from the Israel newborn screening program. J. Inherit. Metab. Dis.39 (2), 211–217 (2016).
   PubMed Web of Science ®Google Scholar
• Al-Shamsi A , HertecantJL, SouidAK, Al-JasmiFA. Whole exome sequencing diagnosis of inborn errors of metabolism and other disorders in United Arab Emirates. Orphanet. J. Rare Dis.11 (1), 94 (2016).
   PubMedGoogle Scholar
• Grunert SC , StuckiM, MorscherRJet al. 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. Orphanet. J. Rare Dis.7, 31 (2012).
   PubMed Web of Science ®Google Scholar
• Jung CW , LeeBH, KimJHet al. Uneventful clinical courses of Korean patients with methylcrotonylglycinuria and their common mutations. J. Hum. Genet.57 (1), 62–64 (2012).
   PubMed Web of Science ®Google Scholar
• Fonseca H , AzevedoL, SerranoC, SousaC, MarcaoA, VilarinhoL. 3-methylcrotonyl-CoA carboxylase deficiency: mutational spectrum derived from comprehensive newborn screening. Gene594 (2), 203–210 (2016).
   PubMed Web of Science ®Google Scholar
• Zandberg L , van DykHC, van der WesthuizenFH, van DijkAA. A 3-methylcrotonyl-CoA carboxylase deficient human skin fibroblast transcriptome reveals underlying mitochondrial dysfunction and oxidative stress. Int. J. Biochem. Cell Biol.78, 116–129 (2016).
   PubMed Web of Science ®Google Scholar
• Jarvinen E , IsmailK, MuniandyMet al. Biotin-dependent functions in adiposity: a study of monozygotic twin pairs. Int. J. Obes.40 (5), 788–795 (2016).
   Web of Science ®Google Scholar
• Baumgartner MR , AlmashanuS, SuormalaTet al. The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. J. Clin. Invest.107, 495–504 (2001).
   PubMed Web of Science ®Google Scholar
• Stadler SC , PolanetzR, MaierEMet al. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Hum. Mutat.27 (8), 748–759 (2006).
   PubMed Web of Science ®Google Scholar
• Abe S , ChamnanC, MiyamotoK, MinaminoY, NoudaM. Isolation and identification of 3-methylcrotonyl coenzyme A carboxylase cDNAs and pyruvate carboxylase, and their expression in red seabream (Pagrus major) organs. Mar. Biotechnol.6 (6), 527–540 (2004).
   PubMed Web of Science ®Google Scholar
• Pang J , LiuWP, LiuXPet al. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. J. Proteome Res.9 (1), 216–226 (2010).
   PubMed Web of Science ®Google Scholar
• Marques RB , DitsNF, Erkens-SchulzeSet al. Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines. PLoS ONE6 (8), e23144 (2011).
   PubMed Web of Science ®Google Scholar
• Baumgartner MR , AlmashanuS, SuormalaTet al. The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. J. Clin. Invest.107 (4), 495–504 (2001).
   PubMed Web of Science ®Google Scholar
• Li X , SunS, LiNet al. High expression of CCR7 predicts lymph node metastasis and good prognosis in triple negative breast cancer. Cell Physiol. Biochem.43 (2), 531–539 (2017).
   PubMedGoogle Scholar
• Harms K , WittekindC. Prognosis of women with pT4b breast cancer: the significance of this category in the TNM system. Eur. J. Surg. Oncol.35 (1), 38–42 (2009).
   PubMed Web of Science ®Google Scholar
• Nottegar A , VeroneseN, SenthilMet al. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: a systematic review and an exploratory meta-analysis. Eur. J. Surg. Oncol.42 (7), 919–925 (2016).
   PubMed Web of Science ®Google Scholar
• Urrutia G , LauritoS, MarzeseDMet al. Epigenetic variations in breast cancer progression to lymph node metastasis. Clin. Exp. Metastasis32 (2), 99–110 (2015).
   PubMed Web of Science ®Google Scholar